Disclosed are methods of inhibiting bone resorption and/or promoting bone
formation using GLP-2 and related Compounds. The invention has a wide spectrum
of important uses including hyperparathyroidism, Paget's disease, hypercalcemia
of malignancy, osteolytic lesions produced by bone metastasis, bone loss due to
immobilisation or sex hormone deficiency, osteomalacia, hyperostosis and osteopetrosis.